Dr. Silveira is interested in clinical research that promotes the health of the patients in her care. As such, some of her projects include the study of the effectiveness of the influenza vaccine in preventing hospital admissions; clinical trials of new agents to treat respiratory viral infections in the immunocompromised; and clinical trials of new agents for the treatment of CMV.
Dr. Silveira's clinical interest is in infectious in organ transplant recipients, particularly respiratory virus infections, infections due to resistant CMV and fungal infections.
Dr. Silveira is the director of the Problem Based Learning (PBL) component of the Medical Microbiology course. She is also interested in teaching of Transplant Infectious Diseases to residents, fellows and general ID practitioners. She participated in the development of the recommended curriculum for training in Transplant Infectious Diseases. She is frequently asked to speak on different topics in Transplant Infectious Diseases at national and international webinars and conferences.
- MD, Federal University of Rio de Janeiro, Brazil, 1998
- MS, University of Pittsburgh, 2009
- Residency, Internal Medicine, University of Miami - Jackson Memorial Hospital, 2003
- Fellowship, Infectious Diseases, University of Pittsburgh Medical Center, 2005
- Fellowship, Transplant Infectious Diseases, University of Pittsburgh Medical Center, 2006
Education & Training
Hughes K, Middleton DB, Nowalk MP, Balasubramani GK, Martin ET, Gaglani M, Talbot HK, Patel MM, Ferd. Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in immunocompromised adults. Clin Infect Dis. 2021
Singh N, Winston DJ, Razonable RR, Lyon GM, Silveira FP, Wagener MM, Stevens-Ayers T, Edmison B, Boe. Effect of preemptive therapy vs antiviral prophylaxis on cytomegalovirus disease in seronegative liver transplant recipients with seropositive donors: a randomized clinical trial. JAMA. 2020; 323(14): 1378-1287.
Papanicolaou GA, Silveira FP, Langston AA, Pereira MM, Avery RK, Uknis M, Wijatyk A, Wu J, Boeckh M. Maribavir for refractory or resistant cytomegalovirus infections in hematopoietic-cell or solid-organ transplant recipients: a randomized, dose-ranging, double-blind, phase 2 study. Infect Dis. 2019; 68(8): 1255-1264.
De La Cruz O, Minces LR, Silveira FP. Experience with linezolid for the treatment of nocardiosis in organ transplant recipients. J Infect. 2015; 70(1): 44-51.
Silveira FP, Kusne S. AST Infectious Diseases Community of Practice. Candida infections in solid organ transplantation. Am J Transplant. 2013; Mar13 Suppl4: 220-7.
Garonzik SM, Li J, Thamlikitkul V, Paterson D, Shoham S, Jacob J, Silveira FP, Forrest A,, Nation RL. Population pharmacokinectics of colistin methanesulfonate and formed colistin in critically-ill patients from a multi-center study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother. 2011; 55(7): 3284-3294.
Avery R, Clauss H, Danziger-Isakov L, Davis J, Doucette K, van Duin D,, Fishman J, Gunseren F, Humar A, Husain S, Isada C, Julian K, Kaul D, Kumar D, Martin S, Michaels M,, Morris M, Silveira F, Subramanian A. Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation Infectious Diseases Community of Practice Educational Initiatives Working Group. Transpl Infect Dis. 2010; 12(3): 190-194.
Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, Danziger-Isakov L, Stosor V,, Estabrook M, Gantt S, Marr KA, Martin S, Silveira FP, Razonable RR, Allen UD, Levi ME, Lyon GM,, Bell LE, Huprikar S, Patel G, Gregg KS, Pursell K, Helmersen D, Julian KG, Shiley K, Bono B, Dharnidharaka VR, Alavi G, Kalpoe JS, Shoham S, Reid GE, Humar A, on behalf of the American Society of Transplantation H1N1 Collaborative Study Group. Outcomes from pandemic influenza A H1N1 infections in recipients of solid-organ transplants: a multicenter cohort. Lancet Infect Dis. 2010; 10(8): 521-526.
- Best Doctors in America, 2015, 2019, 2020
- Chair (Elected), Infectious Diseases Council, International Society for Heart and Lung Transplantation, 2013-2015
- Fellow, Infectious Diseases Society of America, 2018
- Member-at-large (elected), Infectious Diseases Community of Practice of the American Society of Transplantation
- Fellow, American Society of Transplantation, 2021
